AKT1 and cancer: In CRC, the hyperactivated PI3K/Akt signaling pathway positively regulates transcription mediated by NF-κB and β-catenin, which in turn are responsible for the pro-tumorigenic and invasive capacity of cancer cells [4,37,38].